Therapeutic activation of HIF-1α signaling and HIF-1α/FoxM1-dependent vascular repair therefore represents a putative therapeutic strategy for the treatment of inflammatory vascular diseases, such as sepsis and ARDS. This evidence concerns the gene FOXM1 and Sepsis.